AstraZeneca, Korean firm fined by antitrust watchdog over shady deal
Korea's antitrust watchdog said Thursday it has decided to slap a combined 2.6-billion-won ($1.82 million) fine on global pharmaceutical firm AstraZeneca and local generic maker Alvogen on charges of forging a shady deal to avoid competition.